Received Jun 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLUN4 | INFLUENZA (SEASONAL) (FLUMIST QUADRIVALENT) | MEDIMMUNE VACCINES, INC. | UNK | — | — |
Around 2010, FLM was administered to the child who studying abroad, and the patient developed influenza; A spontaneous report has been received from a other health professional via License Partner. The report concerns a patient of unknown gender (age not provided). No medical history was reported. No concomitant products were reported. The patient started treatment with Flumist Quadrivalent (flumist, influenza virus vaccine polyvalent, q/laiv) UNK, on an unknown date for vaccination. No malfunction has been reported for the Accuspray Single Dose device. On an unknown date, the patient experienced around 2010, flm was administered to the child who studying abroad, and the patient developed influenza (preferred term: Influenza). The outcome of the event(s) of around 2010, flm was administered to the child who studying abroad, and the patient developed influenza was unknown. The event was considered non-serious. The reporter considered that there was a reasonable possibility of a causal relationship between Accuspray Single Dose and the following event(s): around 2010, flm was administered to the child who studying abroad, and the patient developed influenza. The reporter considered that there was a reasonable possibility of a causal relationship between Flumist Quadrivalent and the following event(s): around 2010, flm was administered to the child who studying abroad, and the patient developed influenza. Report received by AstraZeneca via License Partner on 12-JUN-25. Device Information: Combination Product Report: Yes Product As Reported: Flumist Quadrivalent Brand Name: FLUMIST QUADRIVALENT Product Role:Suspect Device Problem code:Adverse Event Without Identified Device or Use Problem Manufacturer Name:ASTRAZENECA Labeled for single use:No
Medical History/Concurrent Conditions: Vaccination